Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
BMJ Case Rep ; 20132013 Dec 16.
Article in English | MEDLINE | ID: mdl-24343800

ABSTRACT

We present the case of a 60-year-old woman who developed peripheral T-cell lymphoma following successful treatment for high-grade B-cell non-Hodgkin's lymphoma. We consider the possible aetiology of this unusual occurrence. We hypothesise that this case represents one of the undiagnosed adult-onset immunodeficiency, in which the pathogenesis of the patient's T-cell lymphoma may have been in part iatrogenic, namely related to previous immunotherapy with rituximab. We feel this case highlights the importance of rebiopsy in patients with recurrent lymphadenopathy and a history of haematological malignancy and hence acts as an important aide memoir in the investigation of such cases.


Subject(s)
Antibodies, Monoclonal, Murine-Derived , Immunologic Deficiency Syndromes , Immunologic Factors , Lymphoma, Large B-Cell, Diffuse , Lymphoma, T-Cell, Peripheral , Antibodies, Monoclonal, Murine-Derived/adverse effects , Antibodies, Monoclonal, Murine-Derived/immunology , Antibodies, Monoclonal, Murine-Derived/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biopsy , Humans , Immunologic Deficiency Syndromes/complications , Immunologic Factors/adverse effects , Immunologic Factors/immunology , Immunologic Factors/therapeutic use , Lymphoma, Large B-Cell, Diffuse/drug therapy , Lymphoma, Large B-Cell, Diffuse/immunology , Lymphoma, T-Cell, Peripheral/chemically induced , Lymphoma, T-Cell, Peripheral/immunology , Middle Aged , Recurrence , Rituximab
SELECTION OF CITATIONS
SEARCH DETAIL
...